Navigation Links
Injectable, Oral Birth Control Don't Threaten Glucose, Insulin Levels: Study
Date:12/27/2010

MONDAY, Dec. 27 (HealthDay News) -- Injectable and oral birth control do not significantly affect a woman's fasting glucose and insulin levels, according to a new research.

The three-year study is the largest to measure fasting glucose and insulin levels among women using oral (desogestrel), injectable (DMPA), and non-hormonal (bilateral tubal ligation, condom, or abstinence) methods, said the researchers at the University of Texas Medical Branch in Galveston.

They found that women using DMPA experienced slight increases in glucose and insulin levels. Their glucose levels increased steadily during the first 30 months of using DMPA, with the greatest increase occurring during the first six months. These increases, however, were not large enough to cause concern, according to the researchers.

The study appears in the January issue of the journal Obstetrics and Gynecology.

"Previous studies were limited in scope and offered conflicting results, which led physicians to question whether hormonal contraception could lead to diabetes," lead author Dr. Abbey Berenson, professor, Department of Obstetrics and Gynecology and director of the Center for Interdisciplinary Research in Women's Health, said in a UTMB Health news release.

"Further studies are needed to determine how women with diabetes are affected by DMPA and oral contraception, but these results are reassuring for non-diabetic women already receiving the shot or on the pill," she added.

More information

The American Congress of Obstetricians and Gynecologists has more about contraception.

-- Robert Preidt

SOURCE: University of Texas Medical Branch at Galveston, news release, Dec. 20, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. U.S. Teen Birth Rate Hit Record Low in 2009: CDC
2. Identifying Cleft Palate Before Birth of Little Help to Parents
3. No Link Between Heartburn Drugs and Birth Defects: Study
4. Still Too Many Preterm Births in U.S., Report Finds
5. Preterm birth rates improve in most states
6. Citywide smoking ban contributes to significant decrease in maternal smoking, pre-term births
7. Growth defects in cystic fibrosis may start before birth
8. Brain May Be More Developed at Birth Than Thought
9. Sense of Touch Faster in Those Blind From Birth
10. Stillbirth Can Be Devastating, Unpredictable
11. New Moms Brains May Grow After Childbirth
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Injectable, Oral Birth Control Don't Threaten Glucose, Insulin Levels: Study
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
(Date:6/24/2016)... ... 2016 , ... Advanced Plastic Surgery Institute ( http://www.advancedplasticsurgeryinstitute.com ), ... official Medspa Sponsor. Dr. Josh Olson, a board-certified plastic surgeon, owns the practice, ... says the decision to support the pageant in an official capacity is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Southern Illinois ... are co-chairs for the Illinois State Dental Society (ISDS) Foundation’s Mission of Mercy ... Gateway Convention Center in Collinsville. , They expect to treat approximately ...
(Date:6/24/2016)... Austin, TX (PRWEB) , ... June 24, 2016 , ... ... laude graduate, joins Evans Dermatology in the South Lamar location as of July 13, ... Texas Southwestern Medical School. As a medical student, she regularly volunteered at the Agape ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: